Hemo bioscience is pleased to announce that MQC-CAT, a ready-to-use quality control product for manual column agglutination technology (CAT) blood bank testing methods, has received US FDA 510(k) clearance. Validated for use in all manual CAT testing systems currently available in the US, MQC-CAT includes both positive and negative red cells and serums to ensure that ABO and Rh(D) as well as antibody screening and identification reagents are performing as expected.